Abstract

Numerous surveys using different techniques have been conducted in recent years to accurately classify Alzheimer's disease (AD). This research emphasized the identification of AD through neuroimaging data. However, it is important to identify symptoms as soon as possible when the disease-modifying medications function best during infection before a permanent cognitive impairment develops. The use of automated algorithms to detect the early symptom of AD to this information was very important. Machine Learning (ML) has been proposed for the evaluation of various image segmentation and database techniques. In addition, Visual Geometry Group (VGG)-16 et Improved Faster Recurrent Convolutional Neural Network (IFRCNN) method developed for the ImageNet database utilizing the mathematical model based on action recognition as a feature extractor for categorization work. Experiments are being conducted on the Alzheimer's Neuroimaging Initiative (ADNI) dataset, and the proposed system achieves the 98.32 % accuracy level (Tab. 6, Fig. 4, Ref. 34). Text in PDF www.elis.sk. Keywords: mild cognitive impairment, deep learning, Alzheimer's disease, expected risk.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.